Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so familiar routine of Zoom meetings, Skype calls, and deadlines has predictably returned. To cope, we are pursuing the usual ritual of firing up the coffee kettle and brewing cups of stimulation. Our choice today is cinnamon mocha. Yum. Meanwhile, here is the latest menu of tidbits to help you along on your journey. We hope today is productive and meaningful. Stay in touch and stay safe — wear a mask. …

The Moderna (MRNA) Covid-19 vaccine is strongly effective, a development that is building excitement about the potential of controlling the global pandemic, STAT explains. The vaccine reduced the risk of infection by 94.5%. There were 95 cases of infection among patients who received placebo in a 30,000-patient study and only five infections in patients who developed Covid-19 after receiving the vaccine, mRNA-1273. The news comes one week after similar results from Pfizer (PFE) and BioNTech (BNTX), which announced broadly similar results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!